Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

David W. Kimberlin, Penelope M. Jester, Pablo J. Sánchez, Amina Ahmed, Ravit Arav-Boger, Marian G. Michaels, Negar Ashouri, Janet A. Englund, Benjamin Estrada, Richard F. Jacobs, José R. Romero, Sunil K. Sood, M. Suzanne Whitworth, Mark J. Abzug, Mary T. Caserta, Sandra Fowler, Jorge Lujan-Zilbermann, Gregory A. Storch, Roberta L. DeBiasi, Jin Young HanApril Palmer, Leonard B. Weiner, Joseph A. Bocchini, Penelope H. Dennehy, Adam Finn, Paul D. Griffiths, Suzanne Luck, Kathleen Gutierrez, Natasha Halasa, James Homans, Andi L. Shane, Michael Sharland, Kari Simonsen, John A. Vanchiere, Charles R. Woods, Diane L. Sabo, Inmaculada Aban, Huichien Kuo, Scott H. James, Mark N. Prichard, Jill Griffin, Dusty Giles, Edward P. Acosta, Richard J. Whitley, For The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease'. Together they form a unique fingerprint.